Dishman Carbogen Amcis Ltd

NSE: DCAL · BSE: 540701 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹152.41
Market cap: ₹2,390 Cr
Revenue (annual): ₹2,932 Cr
Net profit (annual): ₹97.45 Cr
P/E (TTM): 147.9×Sector 47.4×
Promoter holding: 59.32%+0.00% QoQ
FII holding: 6.86%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Debt & Borrowing 6 Other Announcement 1 Management Change 1 Financial Results 1 Earnings Call 1 Business Update 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

12 Sep 2026 16:25 IST NSE

Business Update

Dishman Carbogen Amcis Business Update

Dishman Carbogen Amcis' subsidiary, Carbogen Amcis AG, successfully completed a US FDA inspection at its Vionnaz, Switzerland site without any observations.

Read the filing ↗